Atlas Trials

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

Clinical trial NCT01712100 · COMPLETED

Trial details

NCT number
NCT01712100
Sponsor
Roxane Laboratories
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hypertension
Start date
2007-08-01
Primary completion
2007-08-01
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.